Este website utiliza cookies que facilitam a navegação, o registo e a recolha de dados estatísticos.
A informação armazenada nos cookies é utilizada exclusivamente pelo nosso websiteAo navegar com os cookies ativos consente a sua utiliza

Saber mais Aceitar Cookies

IGSD 2022 Conference

20 out 2022 a 22 out 2022

GMDI is posting the following information on behalf of our colleagues at Association for Glycogen Storage Disease (AGSD)

IGSD 2022 Call for Abstracts:

AGSD is pleased to announce the IGSD 2022 Conference will take place virtually on October 20-22, 2022, with Q&A sessions taking place the following week.

We welcome abstracts that communicate current research, case studies, educational tools, development of new services and clinics, and public policy efforts that are relevant to the diagnosis, management, and treatment of glycogen storage diseases.
• Abstracts describing original research and related-efforts relevant to glycogen storage diseases must be submitted in English.
• Abstracts submitted for presentation at the IGSD 2022 Conference will be reviewed and a select number of abstracts will be selected for a recorded oral presentation. Other accepted abstracts may be invited to give recorded poster presentations. For accepted abstracts, there will be a live, virtual Question & Answer session.
• Abstracts submitted after the stipulated deadline will not be considered. Authors are strongly advised to submit prior to the deadline. The copyright in the abstracts is retained by the authors; however, the authors give permission to the IGSD 2022 Conference organizing committee to publish the abstracts online as well as a publication of the choosing of the IGSD Steering Committee.

Abstract submission deadline: May 28, 2022

We will inform you if your abstract has been accepted for poster or oral presentation by June 15, 2022.

Abstract Preparation: Please format your submission as shown below and include all authors’ affiliations (Department, Institution, City, State/Province, Country). Organize the abstract using the following headings: Background, Methods, Results, and Conclusions. Abstracts must be written in English using complete sentences. Do not include tables or figures (Tables and Figures will be allowed for the posters of the selected abstracts). The word limit for abstracts is 350 words. Please include funding disclosures and/or clinical trial registration information as appropriate.

Abstract Requirements:

1) Authorship
- The first author of the abstract is the presenting author and will be expected to attend the virtual conference for poster or oral presentation.
- The presenting author must confirm that all co-authors agree with the abstract submission and publication.

2) Conflicts of Interest and Financial Disclosures
- The presenting author is responsible for disclosing the presence or absence of conflict(s) of interest and financial disclosures for all authors during the abstract submission. These disclosures do not count towards the word limit of 350 words.

3) Approval for Research
- All studies involving human subjects or animal models must have received approval by Institutional Review Boards, Institutional Animal Care and Use Committee (IACUC) or other regulatory bodies, as applicable.

4) Abstract Publication
- Accepted abstracts will be published online and in a publication of the choosing of the IGSD Steering Committee.

Abstract Selection Procedure
- All abstracts will be reviewed by the IGSD 2022 Conference Organizing Committee. Authors of accepted abstracts will be notified via e-mail by June 15, 2022. Abstracts may be considered for oral or poster presentation.
- Instructions for the poster or oral presentation format will be sent to you if your abstract is accepted. Authors of oral presentations will be asked to provide learning objectives. Awardees will be notified by June 15, 2022.

Because the accepted abstracts will be published, the IGSD 2022 Conference Organizing Committee will not accept abstracts that do not follow the instructions described in this document.

All submissions are to be delivered via email to: by May 28, 2022





Faculdade de Farmácia da U.L.
Av. Prof. Gama Pinto
1649-003 Lisboa

Contacto: Fernanda Asper
Telefone.: +351 217 946 400
(Chamada para a rede fixa nacional)
Fax: +351 217 946 491


Subscreva a newsletter da SPDM - Sociedade Portuguesa de Doenças Metabólicas